Jeffrey S. Mathiesen
2016 - NeuroBo Pharmaceuticals
In 2016, Jeffrey S. Mathiesen earned a total compensation of $1.7M as Chief Financial Officer at NeuroBo Pharmaceuticals, a 679% increase compared to previous year.
Compensation breakdown
| Bonus | $15,000 |
|---|---|
| Non-Equity Incentive Plan | $97,500 |
| Option Awards | $1,326,718 |
| Salary | $280,645 |
| Other | $97 |
| Total | $1,719,960 |
Mathiesen received $1.3M in option awards, accounting for 77% of the total pay in 2016.
Mathiesen also received $15K in bonus, $97.5K in non-equity incentive plan, $280.6K in salary and $97 in other compensation.
Rankings
In 2016, Jeffrey S. Mathiesen's compensation ranked 5,591st out of 14,075 executives tracked by ExecPay. In other words, Mathiesen earned more than 60.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,591 out of 14,075 | 60th |
Division Manufacturing | 2,018 out of 5,489 | 63rd |
Major group Chemicals And Allied Products | 642 out of 1,895 | 66th |
Industry group Drugs | 483 out of 1,538 | 69th |
Industry Pharmaceutical Preparations | 383 out of 1,176 | 67th |
Source: SEC filing on April 6, 2017.
Mathiesen's colleagues
We found four more compensation records of executives who worked with Jeffrey S. Mathiesen at NeuroBo Pharmaceuticals in 2016.